In separate announcements on…
In separate announcements on Wednesday, a pair of agencies shared [...]
In separate announcements on Wednesday, a pair of agencies shared [...]
With sales of potential blockbuster Lokelma scaling up, AstraZeneca is [...]
Boehringer Ingelheim will pay AimedBio up to $991 million to [...]
Eli Lilly has guided its oral GLP-1 drug candidate orforglipron [...]
After Omeros decided to hit pause on developing its MASP-3 [...]
Just a few months after surfacing at Orca Bio following [...]
The positive readout could move Tukysa, which has been used [...]
With two Trump administration drug pricing deals in the books [...]
BioCryst Pharmaceuticals has struck a $700 million deal to buy [...]
Kailera Therapeutics has raised $600 million to take its lead [...]